A cancer research company from Cheshire has secured a game-changing patent in the US. BiVictriX Therapeutics is developing a drug for the treatment for patients with acute myeloid leukaemia (AML). The patent has been granted by the United States Patent and Trademark Office (USPTO) and provides broad protection for the company’s lead therapeutic drug – … Continue reading Cancer research company secures game-changing US patent